πŸ‡ΊπŸ‡Έ FDA
Patent

US 12291557

Chimeric TIM4 receptors and uses thereof

granted A61KA61K40/11A61K40/31

Quick answer

US patent 12291557 (Chimeric TIM4 receptors and uses thereof) held by Cero Therapeutics Holdings, Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cero Therapeutics Holdings, Inc.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/4257